Quince Therapeutics (QNCX) Prepaid Assets (2018 - 2026)
Quince Therapeutics (QNCX) posted quarterly Prepaid Assets of $431000.0 for Q1 2026, down 80.67% year-over-year from $2.2 million in Q1 2025, and down 32.13% quarter-over-quarter from $635000.0 in Q4 2025.
Quince Therapeutics (QNCX) Prepaid Assets (2018 - 2026) Analysis & Trends
Quince Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $431000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets fell 80.67% year-over-year to $431000.0; the TTM figure through Mar 2026 stood at $431000.0 (down 80.67% YoY), while the FY2025 annual figure was $635000.0, up 77.87% from the prior year.
- Prepaid Assets for Q1 2026 stood at $431000.0, down from $635000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $3.9 million in Q3 2022, with the low at $55000.0 in Q3 2024.
- The 5-year median for Prepaid Assets is $431000.0 (2026), against an average of $848941.2.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets jumped 694.55% in 2022, then tumbled 96.2% in 2024.
- Quince Therapeutics' Prepaid Assets stood at $276000.0 in 2022, then sank by 70.65% to $81000.0 in 2023, then surged by 340.74% to $357000.0 in 2024, then surged by 77.87% to $635000.0 in 2025, then plunged by 32.13% to $431000.0 in 2026.
- Business Quant data shows QNCX's Prepaid Assets at $431000.0 in Q1 2026, $635000.0 in Q4 2025, and $96000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 431,000.00 |
| Dec 31, 2025 | 635,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 321,000.00 |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 357,000.00 |
| Sep 30, 2024 | 55,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 81,000.00 |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 3.93 Mn |
| Jun 30, 2022 | 387,000.00 |
| Mar 31, 2022 | 487,000.00 |
| Dec 31, 2021 | 4.87 Mn |
| Sep 30, 2021 | 495,000.00 |
| Jun 30, 2021 | 438,000.00 |